Clinical Trials Directory

Trials / Completed

CompletedNCT02759146

Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
347 (actual)
Sponsor
Michigan State University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare reflexology to meditative practices to reduce symptoms in cancer patients.

Detailed description

First, dyads were randomized to receive caregiver-delivered reflexology or meditative practice. Fatigue severity was assesses weekly via phone calls to the cancer patients during weeks 1-4 of the intervention. For patients who did not respond to the intervention during the first 4 weeks, those dyads were referred to as non-responder and re-randomized. A non-responder was determined if the level of reported fatigue remained the same or increased from the first week of the intervention. The re-randomization placed the non-responders in either a group that received a higher dose (more time) with the first intervention or to the alternate practice (meditative practice to those randomized to reflexology and vice versa) for weeks 5-8. Those who did respond during weeks 1-4 continued the same therapy they began with.

Conditions

Interventions

TypeNameDescription
OTHERReflexologyReflexology is a specialized foot therapy that applies a firm walking motion pressure to the feet. It is based on the premise that the foot has reflexes that mirror the rest of the body. It has been shown to reduce symptoms.
OTHERMeditative PracticesMeditative Practices include elements of meditation, gentle yoga and breathing exercises. These practices focus purposeful attention to the present moment and have been shown to enhance one's ability to adapt to serious health concerns

Timeline

Start date
2016-05-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2016-05-03
Last updated
2020-12-16
Results posted
2020-12-16

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02759146. Inclusion in this directory is not an endorsement.